Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK EPRIC: Bl-04 Probiotic for Rhinovirus-Induced Common Cold
NCT02679807Completed
- Sponsor
- University of Virginia
- Start
- Feb 2016
- Primary completion
- Apr 2018
- Modality
- Live Biotherapeutic Products
01
Overview
Randomised, double-blind trial in common cold comparing Bifidobacterium lactis Bl-04 with Placebo (2 arms). Primary endpoint: Number of Participants With Rhinovirus-associated Illness Episodes at 5 days. Started Feb 2016; status: completed.
02
Drugs
bifidobacterium lactis Bl-04
03
Conditions
common cold
Beyond the preview
Go deeper on NCT02679807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679807.